gabexate has been researched along with Blood Poisoning in 4 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We retrospectively evaluated and compared the efficacies of rhTM and gabexate mesilate (GM) in patients diagnosed with sepsis-induced DIC." | 7.80 | A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients. ( Imamura, Y; Izumikawa, K; Kohno, S; Matsuo, N; Miyazaki, T; Nakamura, S; Sawai, T; Suyama, N; Takazono, T; Yanagihara, K; Yoshioka, S, 2014) |
| " We retrospectively evaluated and compared the efficacies of rhTM and gabexate mesilate (GM) in patients diagnosed with sepsis-induced DIC." | 3.80 | A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients. ( Imamura, Y; Izumikawa, K; Kohno, S; Matsuo, N; Miyazaki, T; Nakamura, S; Sawai, T; Suyama, N; Takazono, T; Yanagihara, K; Yoshioka, S, 2014) |
| "Whereas in DIC associated with trauma, since balance between coagulation and fibrinolysis collapses drastically in a short period, both anticoagulantion therapy and antifibrinolytic therapy can be utilized depending on clinical conditions." | 2.53 | [Anti DIC therapy]. ( Sakamoto, Y; Yahata, M, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gando, S | 1 |
| Saitoh, D | 1 |
| Ishikura, H | 1 |
| Ueyama, M | 1 |
| Otomo, Y | 1 |
| Oda, S | 1 |
| Kushimoto, S | 1 |
| Tanjoh, K | 1 |
| Mayumi, T | 1 |
| Ikeda, T | 1 |
| Iba, T | 1 |
| Eguchi, Y | 1 |
| Okamoto, K | 1 |
| Ogura, H | 1 |
| Koseki, K | 1 |
| Sakamoto, Y | 2 |
| Takayama, Y | 1 |
| Shirai, K | 1 |
| Takasu, O | 1 |
| Inoue, Y | 1 |
| Mashiko, K | 1 |
| Tsubota, T | 1 |
| Endo, S | 1 |
| Takazono, T | 1 |
| Nakamura, S | 1 |
| Imamura, Y | 1 |
| Yoshioka, S | 1 |
| Miyazaki, T | 1 |
| Izumikawa, K | 1 |
| Sawai, T | 1 |
| Matsuo, N | 1 |
| Yanagihara, K | 1 |
| Suyama, N | 1 |
| Kohno, S | 1 |
| Akahoshi, T | 1 |
| Sugimori, H | 1 |
| Kaku, N | 1 |
| Tokuda, K | 1 |
| Nagata, T | 1 |
| Noda, E | 1 |
| Morita, M | 1 |
| Hashizume, M | 1 |
| Maehara, Y | 1 |
| Yahata, M | 1 |
1 review available for gabexate and Blood Poisoning
| Article | Year |
|---|---|
[Anti DIC therapy].
Topics: Anticoagulants; Antifibrinolytic Agents; Antithrombins; Benzamidines; Disseminated Intravascular Coa | 2016 |
1 trial available for gabexate and Blood Poisoning
| Article | Year |
|---|---|
A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis.
Topics: Aged; Antithrombins; Blood Coagulation; Disseminated Intravascular Coagulation; Drug Administration | 2013 |
2 other studies available for gabexate and Blood Poisoning
| Article | Year |
|---|---|
A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
Topics: Aged; Aged, 80 and over; Analysis of Variance; C-Reactive Protein; Disseminated Intravascular Coagul | 2014 |
Comparison of recombinant human thrombomodulin and gabexate mesylate for treatment of disseminated intravascular coagulation (DIC) with sepsis following emergent gastrointestinal surgery: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Critical Care; Disseminated Intravascular Coagulatio | 2015 |